TLR5 enhances T-cell activation
Shaikh Atif and co-workers demonstrate that dendritic cell Toll-like receptor 5 (TLR5) enhances the expansion of flagellin-specific T cells to low antigen doses via a mechanism that is independent of NLRC4 and MyD88. See page 68
TLR agonists enhance lung epithelial cell defenses
Jeffrey Cleaver and colleagues show that local application of Toll-like receptor (TLR) 2/6 and 9 agonists protects against lethal pulmonary bacterial infections by activating epithelial cells' innate defenses. See page 78 
Alveolar macrophages targeted for influenza vaccination

HIF-1a and barrier function
Simon Keely and colleagues observed that pharmacological stabilization of hypoxia-inducible factor (HIF) through prolyl hydroxylase inhibition results in enhanced intestinal barrier function as well as protection against systemic bacteremia following epithelial cell damage. See page 114
Depletion of Th22 cells in UC
Jacqueline Leung and co-workers provide evidence that increased transforming growth factor-β production in inflamed tissues from patients with ulcerative colitis (UC) may deplete local T helper type 22 (Th22) cells and affect the intestinal microbiome. See page 124 γδ IELs in mucosal healing during colitis
Terrence Meehan and colleagues demonstrate that CD100-mediated signals are critical for effective activation of intraepithelial γδ T cells (γδ IELs) to produce growth factors, including keratinocyte growth factor-1, that are required for healing of the colonic epithelium during colitis. See page 134 
IL-22 in innate colitis
